Your browser doesn't support javascript.
loading
Illuminating a Dark Kinase: Structure-Guided Design, Synthesis, and Evaluation of a Potent Nek1 Inhibitor and Its Effects on the Embryonic Zebrafish Pronephros.
Baumann, Georg; Meckel, Tobias; Böhm, Kevin; Shih, Yung-Hsin; Dickhaut, Mirco; Reichardt, Torben; Pilakowski, Johannes; Pehl, Ulrich; Schmidt, Boris.
Affiliation
  • Baumann G; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Meckel T; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Böhm K; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Shih YH; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Dickhaut M; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Reichardt T; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Pilakowski J; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
  • Pehl U; Merck Healthcare KGaA, Biopharma R&D, Discovery and Development Technologies, 64293 Darmstadt, Germany.
  • Schmidt B; Clemens Schöpf-Institute of Organic Chemistry and Biochemistry, Technische Universität Darmstadt, 64287 Darmstadt, Germany.
J Med Chem ; 65(2): 1265-1282, 2022 01 27.
Article in En | MEDLINE | ID: mdl-35081715
ABSTRACT
NIMA-related kinase 1 (Nek1) has lately garnered attention for its widespread function in ciliogenesis, apoptosis, and the DNA-damage response. Despite its involvement in various diseases and its potential as a cancer drug target, no directed medicinal chemistry efforts toward inhibitors against this dark kinase are published. Here, we report the structure-guided design of a potent small-molecule Nek1 inhibitor, starting from a scaffold identified by kinase cross-screening analysis. Seven lead compounds were identified in silico and evaluated for their inhibitory activity. The top compound, 10f, was further profiled for efficacy, toxicity, and bioavailability in a zebrafish polycystic kidney disease model. Administration of 10f caused the expansion of fluorescence-labeled proximal convoluted tubules, supporting our hypothesis that Nek1-inhibition causes cystic kidneys in zebrafish embryos. Compound 10f displayed insignificant inhibition in 48 of 50 kinases in a selectivity test panel. The findings provide a powerful tool to further elucidate the function and pharmacology of this neglected kinase.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Protein Kinase Inhibitors / Embryo, Nonmammalian / Pronephros / NIMA-Related Kinase 1 / Polycystic Kidney Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2022 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Protein Kinase Inhibitors / Embryo, Nonmammalian / Pronephros / NIMA-Related Kinase 1 / Polycystic Kidney Diseases Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2022 Document type: Article Affiliation country: Germany
...